Cite Filings / XFOR / 0001628280-23-038334

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

X4 Pharmaceuticals, Inc Filed 2023-11-09 Acc 0001628280-23-038334

Documents 1

10-Q Quarterly Report , xfor-20230930.htm

Around this filing

2024-05-07 10-Q Quarterly Report
2023-11-14 8-K Delisting notice
2023-11-09 10-Q Quarterly Report
2023-11-09 8-K Results of operations
2023-11-03 4 Chief Financial Officer sold 230,645 shares at $0.73 ($168,371)
2023-11-03 4 Chief Operating Officer sold 67,695 shares at $0.73 ($49,417)
2023-08-10 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading xfor-20230930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…